On May 12, 2020, Minerva Surgical, Inc, acquired the following Intrauterine Health products from Boston Scientific: the Symphion™ Tissue Removal System; the Resectr™ Tissue Resection Device; and the Genesys HTA™ System. For more information, please visit Minerva Surgical or email meetminerva@minervasurgical.com.
Gynecology
Whether treating menorrhagia or removing fibroids and polyps, we know only one thing matters to you: helping your patients get back to their lives. Our gynecology portfolio includes three minimally invasive surgical solutions: Genesys HTA™ System, Symphion™ System and Resectr™ Tissue Resection Device. Together, they give you the flexibility you need to see and treat these uterine conditions.



References
- ACOG Patient FAQ Endometrial Ablation, https://www.acog.org/~/media/For%20Patients/faq134.pdf. Accessed February 19, 2016.
- Reilly GP, Savells A. Can endometrial ablation technique effectiveness be properly compared without considering the uteruses treated? A retrospective review of 172 cases of HTA, Novasure and ThermaChoice. J Minim Invasive Gynecol. 2008 Nov-Dec;15(6 Suppl):23S.